Detalhe da pesquisa
1.
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med
; 386(9): 847-860, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139271
2.
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med
; 384(23): 2187-2201, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882225
3.
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
Lancet
; 384(9961): 2213-27, 2014 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25189358
4.
One virus, one lesion--individual components of CIN lesions contain a specific HPV type.
J Pathol
; 227(1): 62-71, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22127961
5.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncol
; 13(1): 100-10, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075170
6.
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans.
CPT Pharmacometrics Syst Pharmacol
; 12(10): 1485-1498, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715342
7.
Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
Vaccine
; 41(37): 5351-5359, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517912
8.
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Infect Dis
; 22(12): 1703-1715, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113538
9.
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine.
Hum Vaccin
; 6(12): 1054-61, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21157180
10.
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.
Gynecol Oncol
; 115(3 Suppl): S1-6, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19217149
11.
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials.
Hum Vaccin
; 5(5): 332-40, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19221517
12.
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Sci Rep
; 9(1): 14476, 2019 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597922
13.
Ulna/height ratio as clinical parameter separating EXT1 from EXT2 families?
Genet Test
; 12(1): 129-33, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18373409
14.
Vaccine strategies: Optimising outcomes.
Vaccine
; 34(52): 6691-6699, 2016 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27887796
15.
Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
Vaccine
; 34(12): 1436-43, 2016 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873055
16.
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
Lancet Infect Dis
; 16(10): 1154-1168, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27373900
17.
Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
Pediatr Infect Dis J
; 24(9): 807-16, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16148848
18.
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
Vaccine
; 33(22): 2594-601, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882172
19.
Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Vaccine
; 33(23): 2727-33, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962750
20.
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents--A single blind randomized trial.
Hum Vaccin Immunother
; 11(7): 1770-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26075317